CSI Market
Sign In | Register

Conmed (CNMD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CNMD Annual Cash Flow →
The table below presents a historical view of Conmed's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income36.90
Depreciation & amortization8.25
Amortization of Other Assets49.46
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.61
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories13.71
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.14
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt6.21
Write Off Of Deferred Debt Issuance Cost-
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost-
Gain On Sale Of A Product Line-3.92
Income taxes0.00
Gain (Loss) on Sale of Properties0.00
Accounts Receivable-18.96
Increase (Decrease) in Accounts Payable6.23
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital9.83
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-61.81
Discontinued operations0.00
Net Cash flow from Operating Activities50.57
Investing Activities
Capital Expenditures-5.83
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments Related To Business Acquisitions And Distribution Agreement-
Payments Related To Distribution Agreement-
Paymentsto Acquire Businesses Net of Cash Acquired and Asset Acquisitions-
Paymentsrelatedtobusinessacquisitionsandassetacquisitions-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net21.50
Discontinued operations0.00
Net Cash Flow from Investing Activities15.67
Financing Activities
Short-term debt Net193.00
Other borrowing transactions-3.55
Long-term debt - borrowings450.00
Long-term debt - repayments-637.18
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-43.22
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net1.01
Other net-28.85
Payments For Contingent Payments-
Payments for Contingent Consideration Relatedto Business Acquisition-
Payments for Contingent Consideration Relatedto Asset Acquisition-
Payments Of Convertible Hedges-
Purchases of Convertible Notes Hedges-
Payments For Contingent Consideration-11.36
Payments For Convertible Notes Hedges-
Payments Of Convertible Notes Hedges-
Proceeds From Settlement Of Convertible Notes Hedge Transactions-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-68.79
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow44.74
Total Cash Flow-3.49
4 historic quarters locked

Sign in to unlock the full Conmed cash flow history.

Sign In Create Free Account

About Conmed Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000816956-26-000102

Figures are derived from filed reports and may be restated. Historical data is subject to revision.